- Home
- PYPL vs GSK Comparison
PYPL vs GSK Comparison
Compare PYPL & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPL
- GSK
- Stock Information
- Founded
- PYPL 1998
- GSK 1715
- Country
- PYPL United States
- GSK United Kingdom
- Employees
- PYPL N/A
- GSK N/A
- Industry
- PYPL Business Services
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- PYPL Consumer Discretionary
- GSK Health Care
- Exchange
- PYPL Nasdaq
- GSK Nasdaq
- Market Cap
- PYPL 68.8B
- GSK 74.6B
- IPO Year
- PYPL 2002
- GSK N/A
- Fundamental
- Price
- PYPL $65.15
- GSK $38.73
- Analyst Decision
- PYPL Buy
- GSK Hold
- Analyst Count
- PYPL 32
- GSK 4
- Target Price
- PYPL $92.11
- GSK $47.00
- AVG Volume (30 Days)
- PYPL 11.4M
- GSK 4.8M
- Earning Date
- PYPL 04-29-2025
- GSK 04-30-2025
- Dividend Yield
- PYPL N/A
- GSK 4.00%
- EPS Growth
- PYPL 3.91
- GSK N/A
- EPS
- PYPL 3.99
- GSK 0.78
- Revenue
- PYPL $31,797,000,000.00
- GSK $39,280,393,592.00
- Revenue This Year
- PYPL $5.97
- GSK $7.60
- Revenue Next Year
- PYPL $6.56
- GSK $5.24
- P/E Ratio
- PYPL $16.33
- GSK $24.37
- Revenue Growth
- PYPL 6.80
- GSK 3.46
- 52 Week Low
- PYPL $56.97
- GSK $31.72
- 52 Week High
- PYPL $93.66
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- PYPL 31.75
- GSK 52.73
- Support Level
- PYPL $68.55
- GSK $37.76
- Resistance Level
- PYPL $71.71
- GSK $39.31
- Average True Range (ATR)
- PYPL 1.75
- GSK 0.52
- MACD
- PYPL 0.29
- GSK -0.26
- Stochastic Oscillator
- PYPL 2.96
- GSK 35.79
About PYPL PayPal Holdings Inc.
PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 434 million active accounts at the end of 2024. The company also owns Venmo, a person-to-person payment platform.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.